Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

June 9, 2014

Primary Completion Date

March 27, 2017

Study Completion Date

April 12, 2017

Conditions
Respiratory Syncytial Virus Infection
Interventions
DRUG

Presatovir

Presatovir 200 mg (4 x 50 mg tablets) administered orally

DRUG

Presatovir placebo

Presatovir placebo tablets administered orally

Trial Locations (43)

Unknown

Northwestern Memorial Hospital, Chicago

Anne Arundel Medical Center, Annapolis

Henry Ford Health System, Detroit

William Beaumont, Royal Oak

New York Presbyterian Hospital, New York

Rochester General Hospital, Rochester

Vanderbilt Medical Group and Clinic, Nashville

University of Washington, Seattle

Marshfield Clinic Research Foundation, Marshfield

John Hunter Hospital, New Lambton

Westmead Hospital, Westmead

Redcliffe Hospital, Redcliffe

Gold Coast Hospital, Southport

Monash Medical Center, Clayton

Frankston Hospital, Frankston

Universite Liebre de Bruxelles - Hopital Erasme, Anderlecht

Hopital Foch, Suresnes

CHRU Brest - Hospital Cavale Blanche, Brest

Hopital d'Instructions des Armees Percy, Clamart

Hopital Louis Mourier, Colombes

Hopital Saint Louis - Service de Pneumologie, Paris

Hopital Tenon, Paris

Soroka Medical Center, Beersheba

Edith Wolfson Medical Center, Holon

Hadassah University Hospital Ein Kerem, Jerusalem

Meir Medical Center, Kefar Sava

Western Galilee Hospital-Nahariya, Nahariya

The Nazareth Hospital, Nazareth

Rabin Medical Center, Petah Tikva

Chaim Sheba Medical Center, Ramat Gan

Sourasky Medical Center, Tel Aviv

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan

Gelre Ziekenhuizen, Zutphen

Tauranga Hospital, Tauranga

Middlemore Hospital, Auckland

Waikato Hospital, Hamilton

Centrum Badan Klinicznych, Wroclaw

Soon Chun Hyang University Hospital, Bucheon-si

Gachon University Gil Hospital, Incheon

Asan Medical Center, Seoul

Seoul National University Hospital, Seoul

Southampton University Hospitals NHS Trust, Southampton

Princess Royal Hospital, Telford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT02135614 - Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection | Biotech Hunter | Biotech Hunter